{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:28:00Z","timestamp":1789475280329,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We decided to compare some inflammatory, and oxidative stress markers, as well as lipid profiles between the obese and non-obese patients with type 2 diabetes considering ApoB gene polymorphism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>one-hundred sixty two patients with type 2 diabetes were included in this study. ApoB genotyping was conducted by the polymerase chain reaction. Serum interleukin-(IL-18), pentraxin-3 (PTX-3), and high sensitive- C reactive protein (hs-CRP) was measured as the inflammatory markers. Moreover, copper-zinc superoxide dismutase (Cu\/Zn-SOD), total antioxidant capacity (TAC) and 8-isoprostane F2\u03b1 were analyzed for oxidative stress assessment. Anthropometric indices and lipid profiles were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Adjusted for confounders, serum hs-CRP (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), LDL-C (<jats:italic>p<\/jats:italic>\u2009=\u20090.01), LDL-C\/HDL-C (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), and TG (<jats:italic>p<\/jats:italic>\u2009=\u20090.02) were significantly lower at the Homozygous Insertion (Ins)\/Ins <jats:italic>vs.<\/jats:italic> deletion (Del) allele carriers in the obese patients. Serum TAC was significantly lower at the obese Del allele carriers than Ins\/Ins Homozygous (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). Serum hs-CRP (<jats:italic>p<\/jats:italic>\u2009=\u20090.006), and 8-IsoprostanF2\u03b1 (<jats:italic>P<\/jats:italic>\u2009=\u20090.04) were significantly higher in the obese Del allele carriers than non-obese. Serum Cu\/Zn-SOD was significantly higher in the non-obese Del allele carriers than obese (<jats:italic>p<\/jats:italic>\u2009=\u20090.04).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Inflammation, dyslipidemia, and oxidative stress are higher in the Obese Del allele carriers with type 2 diabetes which prone them to other chronic disorders.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-00991-y","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T09:04:05Z","timestamp":1647939845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Deletion allele of Apo B gene is associated with higher inflammation, oxidative stress and dyslipidemia in obese type 2 diabetic patients: an analytical cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Nasim","family":"Mokhtary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Neda","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gity","family":"Sotoudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Qorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Koohdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"991_CR1","unstructured":"Alalawi, H.H. and S.A. MANAL, Detection of Cardiovascular Disease using Machine Learning Classification Models. INTERNATIONAL JOURNAL OF ENGINEERING RESEARCH & TECHNOLOGY (IJERT) ISSN: p. 2278\u20130181."},{"key":"991_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cca.2014.08.018","volume":"438","author":"I Cruz-Bautista","year":"2015","unstructured":"Cruz-Bautista I, et al. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia. Clin Chim Acta. 2015;438:160\u20135.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"991_CR3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","volume":"5","author":"I Mart\u00edn-Tim\u00f3n","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, et al. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5(4):444.","journal-title":"World J Diabetes"},{"key":"991_CR4","unstructured":"Chadt, A., et al., Molecular links between obesity and diabetes:\u201cdiabesity\u201d. Endotext [Internet], 2018."},{"issue":"5","key":"991_CR5","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3390\/ijms12053117","volume":"12","author":"A Fern\u00e1ndez-S\u00e1nchez","year":"2011","unstructured":"Fern\u00e1ndez-S\u00e1nchez A, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12(5):3117\u201332.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"991_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-017-0678-6","volume":"19","author":"AJ Kattoor","year":"2017","unstructured":"Kattoor AJ, et al. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):1\u201311.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"991_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","volume":"6","author":"S Tangvarasittichai","year":"2015","unstructured":"Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6(3):456.","journal-title":"World J Diabetes"},{"issue":"3","key":"991_CR8","first-page":"193","volume":"70","author":"P Holvoet","year":"2008","unstructured":"Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg. 2008;70(3):193\u2013219.","journal-title":"Verh K Acad Geneeskd Belg"},{"issue":"3","key":"991_CR9","first-page":"301","volume":"2","author":"M Rafiee","year":"2016","unstructured":"Rafiee M, et al. Association between Insertion\/Deletion Polymorphism of ApoB Gene with Dyslipidemia and Obesity Risk in Patients with Type 2 Diabetes. J Obes Overweig. 2016;2(3):301.","journal-title":"J Obes Overweig"},{"issue":"3","key":"991_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","volume":"259","author":"PJ Barter","year":"2006","unstructured":"Barter PJ, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel. J Intern Med. 2006;259(3):247\u201358.","journal-title":"J Intern Med"},{"key":"991_CR11","unstructured":"Organization, W.H., Obesity: preventing and managing the global epidemic. 2000."},{"issue":"5","key":"991_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1017\/S1368980009991698","volume":"13","author":"P Mirmiran","year":"2010","unstructured":"Mirmiran P, et al. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654\u201362.","journal-title":"Public Health Nutr"},{"issue":"3","key":"991_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S MWer","year":"1988","unstructured":"MWer S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids res. 1988;16(3):1215.","journal-title":"Nucleic acids res"},{"issue":"12","key":"991_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","volume":"25","author":"RW Mahley","year":"1984","unstructured":"Mahley RW, et al. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25(12):1277\u201394.","journal-title":"J Lipid Res"},{"issue":"3","key":"991_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10528-011-9468-y","volume":"50","author":"K Tsunoda","year":"2012","unstructured":"Tsunoda K, et al. Polymorphism of the apolipoprotein B gene and association with plasma lipid and lipoprotein levels in the Mongolian Buryat. Biochem Genet. 2012;50(3):249\u201368.","journal-title":"Biochem Genet"},{"issue":"2","key":"991_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0021-9150(02)00425-2","volume":"167","author":"BD Chiodini","year":"2003","unstructured":"Chiodini BD, et al. APO B gene polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis. 2003;167(2):355\u201366.","journal-title":"Atherosclerosis"},{"issue":"9","key":"991_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2459\/JCM.0b013e328364be64","volume":"15","author":"Y-Y Li","year":"2014","unstructured":"Li Y-Y. ApoB gene SpIns\/Del, XbaI polymorphisms and myocardial infarction: a meta-analysis of 7169 participants. J Cardiovasc Med. 2014;15(9):717\u201326.","journal-title":"J Cardiovasc Med"},{"key":"991_CR18","doi-asserted-by":"crossref","unstructured":"Al-Bustan, S.A., et al.,Increased Risk of the APOB rs11279109 Polymorphism for CHD among the Kuwaiti Population. Disease markers, 2017. 2017.","DOI":"10.1155\/2017\/6963437"},{"issue":"3","key":"991_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-0004.1993.tb03861.x","volume":"44","author":"N Saha","year":"1993","unstructured":"Saha N, et al. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet. 1993;44(3):113\u201320.","journal-title":"Clin Genet"},{"issue":"2","key":"991_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0009-9120(01)00184-9","volume":"34","author":"JA Hubacek","year":"2001","unstructured":"Hubacek JA, et al. Genetic determination of plasma lipids and insulin in the Czech population. Clin Biochem. 2001;34(2):113\u20138.","journal-title":"Clin Biochem"},{"issue":"7","key":"991_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jdiacomp.2015.05.024","volume":"29","author":"F Koohdani","year":"2015","unstructured":"Koohdani F, et al. Association between ApoA-II-265 T\/C polymorphism and oxidative stress in patients with type 2 diabetes mellitus. J Diabetes Complications. 2015;29(7):908\u201312.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"991_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4093\/dmj.2016.40.3.222","volume":"40","author":"F Koohdani","year":"2016","unstructured":"Koohdani F, et al. APO A2\u2013265T\/C polymorphism is associated with increased inflammatory responses in patients with type 2 diabetes mellitus. Diabetes Metab J. 2016;40(3):222\u20139.","journal-title":"Diabetes Metab J"},{"issue":"3","key":"991_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.arteri.2018.03.002","volume":"30","author":"F Arrieta","year":"2018","unstructured":"Arrieta F, et al. Diabetes mellitus Y riesgo cardiovascular. Actualizaci\u00f3n de las recomendaciones del Grupo de Trabajo de diabetes Y Riesgo cardiovascular de la Sociedad Espa\u00f1ola de diabetes (SED, 2018). Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis. 2018;30(3):137\u201353.","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"},{"issue":"1","key":"991_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1573399812666151016101622","volume":"13","author":"M Lotfy","year":"2017","unstructured":"Lotfy M, et al. Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. 2017;13(1):3\u201310.","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"991_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10753-012-9538-2","volume":"36","author":"SJ Piva","year":"2013","unstructured":"Piva SJ, et al. Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index. Inflammation. 2013;36(1):226\u201331.","journal-title":"Inflammation"},{"issue":"1","key":"991_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/ajcn\/64.1.101","volume":"64","author":"M-C Delmas-Beauvieux","year":"1996","unstructured":"Delmas-Beauvieux M-C, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr. 1996;64(1):101\u20137.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"991_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6890-2-3","volume":"2","author":"M Kampa","year":"2002","unstructured":"Kampa M, et al. A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol. 2002;2(1):3.","journal-title":"BMC Clin Pathol"},{"issue":"7","key":"991_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/01.CIR.0000116761.93647.30","volume":"109","author":"E Schwedhelm","year":"2004","unstructured":"Schwedhelm E, et al. Urinary 8-iso-prostaglandin F2\u03b1 as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation. 2004;109(7):843\u20138.","journal-title":"Circulation"},{"issue":"2","key":"991_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","volume":"99","author":"G Dav\u0131\u0300","year":"1999","unstructured":"Dav\u0131\u0300 G, et al. In vivo formation of 8-iso-prostaglandin F2\u03b1 and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.. Circulation. 1999;99(2):224\u20139.","journal-title":"Circulation"},{"issue":"22","key":"991_CR30","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1161\/01.CIR.0000039528.49161.E9","volume":"106","author":"P Minuz","year":"2002","unstructured":"Minuz P, et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 2002;106(22):2800\u20135.","journal-title":"Circulation"},{"issue":"18","key":"991_CR31","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","volume":"332","author":"JD Morrow","year":"1995","unstructured":"Morrow JD, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers\u2014smoking as a cause of oxidative damage. N Engl J Med. 1995;332(18):1198\u2013203.","journal-title":"N Engl J Med"},{"issue":"9","key":"991_CR32","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1161\/ATVBAHA.107.149484","volume":"27","author":"A Zirlik","year":"2007","unstructured":"Zirlik A, et al. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2007;27(9):2043\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-00991-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T09:06:44Z","timestamp":1647940004000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-00991-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-00991-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tehran University of Medical Sciences ethically approved the present study. Informed consent was gathered from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}